227 related articles for article (PubMed ID: 8834886)
21. Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Gelber RH; Siu P; Tsang M; Richard V; Chehl SK; Murray LP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):259-64. PubMed ID: 7602221
[TBL] [Abstract][Full Text] [Related]
22. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
23. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
24. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
25. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
[No Abstract] [Full Text] [Related]
26. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
27. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
28. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
29. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
Ji B
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
[No Abstract] [Full Text] [Related]
30. Antagonism between dapsone and rifampicin in experimental Mycobacterium leprae infections in mice.
Millan JP; Moulia-Pelat JP
Res Microbiol; 1989 Feb; 140(2):143-50. PubMed ID: 2678328
[TBL] [Abstract][Full Text] [Related]
31. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Ji B; Perani EG; Grosset JH
Antimicrob Agents Chemother; 1991 Mar; 35(3):579-81. PubMed ID: 1828136
[TBL] [Abstract][Full Text] [Related]
33. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
34. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
Rao PS; Ramachandran A; Sekar B; Ravi S; Subramanian M
Lepr Rev; 1994 Sep; 65(3):181-9. PubMed ID: 8942149
[TBL] [Abstract][Full Text] [Related]
35. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
Ji B; Jamet P; Perani EG; Bobin P; Grosset JH
J Infect Dis; 1993 Jul; 168(1):188-90. PubMed ID: 8257487
[TBL] [Abstract][Full Text] [Related]
36. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
Dhople AM; Namba K
Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
[TBL] [Abstract][Full Text] [Related]
37. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
[TBL] [Abstract][Full Text] [Related]
38. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
Millan J; Roux G; Loko S; Naudin JC; Boucher P; Bodian M; Camara M; Moreira-Diop T; Grosset J
Acta Leprol; 1986; 4(4):427-44. PubMed ID: 3296613
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the multiplication of Mycobacterium leprae in nude mice by intermittent administration of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin (KRM-1648) combined with sparfloxacin.
Gidoh M; Matsuki G; Tsutsumi S; Hidaka T; Nakamura S
Lepr Rev; 1995 Mar; 66(1):39-47. PubMed ID: 7731340
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
